Bio Products Laboratory Ltd. Sustainability Profile
Bio Products Laboratory Ltd. (BPL) is a leading biopharmaceutical company headquartered in the United Kingdom. Established in 1983, BPL has made significant strides in the development and manufacture of high-quality plasma-derived therapies, primarily serving patients with rare and chronic conditions. With operational facilities in the UK and a growing presence in international markets, BPL is committed to advancing healthcare through innovative solutions. The company’s core products include immunoglobulins, clotting factors, and albumin, all distinguished by their rigorous quality standards and commitment to patient safety. BPL's dedication to research and development has positioned it as a trusted partner in the biopharmaceutical industry, recognised for its contributions to patient care and its robust pipeline of therapies. With a focus on excellence and innovation, Bio Products Laboratory Ltd. continues to enhance its market position and deliver impactful healthcare solutions globally.
DitchCarbon Score
How does Bio Products Laboratory Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bio Products Laboratory Ltd.'s score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bio Products Laboratory Ltd.'s reported carbon emissions
In 2023, Bio Products Laboratory Ltd., headquartered in Great Britain, reported carbon emissions data indicating approximately 6,000 kg CO2e per unit of revenue. This figure reflects their Scope 2 location-based emissions, although specific Scope 1 and Scope 3 emissions data were not disclosed. Currently, Bio Products Laboratory Ltd. does not have any publicly stated reduction targets or commitments under the Science Based Targets initiative (SBTi) or other climate initiatives. The company is classified as a current subsidiary, and any emissions data or climate commitments may be cascaded from its parent organization, although specific details regarding these relationships are not provided. As part of their climate strategy, Bio Products Laboratory Ltd. is expected to align with industry standards and best practices, but further information on their specific initiatives or future targets is not available at this time.
How Carbon Intensive is Bio Products Laboratory Ltd.'s Industry?
How Carbon Intensive is Bio Products Laboratory Ltd.'s Location?
Bio Products Laboratory Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bio Products Laboratory Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
